{"":[],"etf_ticker":"XBI","etf_name":"SPDR S&P BIOTECH ETF","info1":{"box_type":"info","box_name":"ETF Overview","payload":[["Issuer","SSgA","","The name of the company that issues the ETF"],["Fund Type","ETF","","Exchange Traded Products fall under 2 broad categories: ETFs or ETNs"],["Asset Class","Equity","","The general asset class exposure of this ETP"],["Geography","U.S.","","The general geographic exposure of this ETP"],["Strategy","Equal","","The general strategy employed by the fund manager to gain exposure"],["AUM",5.392579e+09,"formatPriceToWords","Assets Under Management. The total shares outstanding multiplied by the last closing price"]],"icon":"fa-info"},"info2":{"box_type":"info","box_name":"ETF Details","payload":[["Peer Group ETFs",["FBT","BBC","BBP","CNCR","RYH"],"createTickerLinks","ETFs that match the current one across various qualititive measures"],["Correlated ETFs",["FBT","SBIO","PTH","BBC","BBP"],"createTickerLinks","Correlated ETFs as measured using 1 year of weekly returns"],["Shared Component ETFs",["FHLC","VHT","IEIH","IBB","ONEQ"],"createTickerLinks","ETFs with a significant percentage of shared basket component weights"],["Fund Inception","2006-01-31","","The date the fund was created"],["Expense Ratio",0.0035,"formatPercent_3decimal","The fee charged by the fund manager"]],"icon":"fa-cog"},"box1":{"box_type":"table","box_name":"Top Holdings","payload":[{"ticker":"ICPT","issuername":"Intercept Pharmaceuticals Inc","countryname":"USA","wgt":0.02007199},
 {"ticker":"REGN","issuername":"Regeneron Pharmaceuticals, Inc.","countryname":"USA","wgt":0.01669929},
 {"ticker":"LGND","issuername":"Ligand Pharmaceuticals, Inc.","countryname":"USA","wgt":0.01651018},
 {"ticker":"HRTX","issuername":"Heron Therapeutics Inc","countryname":"USA","wgt":0.01640227},
 {"ticker":"SRPT","issuername":"Sarepta Therapeutics Inc","countryname":"USA","wgt":0.01636043},
 {"ticker":"ESPR","issuername":"Esperion Therapeutics Inc.","countryname":"USA","wgt":0.01570866},
 {"ticker":"NBIX","issuername":"Neurocrine Biosciences, Inc.","countryname":"USA","wgt":0.01552795},
 {"ticker":"VRTX","issuername":"Vertex Pharmaceuticals, Inc.","countryname":"USA","wgt":0.01550252},
 {"ticker":"BMRN","issuername":"Biomarin Pharmaceutical Inc.","countryname":"USA","wgt":0.01533536},
 {"ticker":"BIIB","issuername":"Biogen Inc","countryname":"USA","wgt":0.01517656}],"table_description":[["ticker","Ticker","text"],["issuername","Name","text"],["countryname","Country Code","text"],["wgt","Basket Weight","percent"]],"icon":"fa-money-check-alt"},"box2":{"box_type":"table","box_name":"Sector Exposure","payload":[{"grouping":"Health Care","wgt":0.9856605},
 {"grouping":"Industrials","wgt":0.01433954},
 {"grouping":"Unknown","wgt":0}],"table_description":[["grouping","Sector","text"],["wgt","Basket Weight","percent"]],"icon":"fa-industry"},"box3":{"box_type":"table","box_name":"Factor Exposure","payload":[{"factors":"US Market Exposure","betas":"5.0"},
 {"factors":"US Size Exposure","betas":"-0.46"},
 {"factors":"US Value/Growth Exposure","betas":"0.31"}],"table_description":[["factors","Factor","text"],["betas","Factor Beta","percent"]],"icon":"fa-plus-circle"},"box4":{"box_type":"table","box_name":"Country Exposure","payload":[{"countryname":"USA","wgt":1}],"table_description":[["countryname","Country","text"],["wgt","Basket Weight","percent"]],"icon":"fa-globe-americas"},"box5":{"box_type":"info","box_name":"Basket Statistics","payload":[["Concentration Score",108.9085,"","The Herfindahl Index calculation on basket weights. The score can range from 0 to 10000. A higher number indicates a higher degree of concentration risk"],["Constituent Count",127,"","The number of components in the fund"],["Median Weight",0.007734,"formatPercent_3decimal","The median weight of all fund constituents"],["Maximum Weight",0.017306,"formatPercent_3decimal","The largest weight of a single fund constituent"]],"icon":"fa-shopping-basket"},"box6":{"box_type":"info","box_name":"Trading Details","payload":[["Average Volume - 20 Days",3844925,"formatNumberToWords","Average of daily traded shares across exchanges and dark pools"],["Median Volume - 60 Days",4359777,"formatNumberToWords","Median of daily traded shares - sometimes used as a better measure to understand fund liquidity on exchange"],["Average ETF Spread",0.0003048515,"formatPercent_3decimal","The average spread of the ETF using 1-minute bid and offer quote samples across a number of days"],["Median ETF Spread",0.0002983143,"formatPercent_3decimal","The median spread of the ETF using 1-minute bid and offer quote samples across a number of days"],["Top-of-Book - Median Bid Size",960.641,"formatNumberToWords","The median displayed bid-side shares using a 1-minute sampled quote across a number of days"],["Top-of-Book - Median Offer Size",939.1026,"formatNumberToWords","The median displayed offer-side shares using a 1-minute sampled quote across a number of days"],["# of Exchanges",4,"","Counts the number of distinct exchanges that have appeared at least once on the best bid or offer of a quote across a number of days"],["# of Days in Calculations",40,"","Number of days of trading data used to calculate these trading details, unless noted otherwise"],["Fund Turnover - 1 month",1.2501e+09,"formatNumberToWords","The sum of all creations and redemptions (inflows and outflows) into the fund. Measures fund-level activity"],["Fund Turnover - 3 months",4.766202e+09,"formatNumberToWords","The sum of all creations and redemptions (inflows and outflows) into the fund. Measures fund-level activity"]],"icon":"fa-asterisk"},"box_keys":["box1","box2","box3","box4","box5","box6"]}
